These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2156074)

  • 21. Studies on the present state of resistance to framycetin among strains of staphylococci, enterobacteriaceae and pseudomonas.
    Knothe H
    Arzneimittelforschung; 1973 Dec; 23(12):1759-60. PubMed ID: 4205906
    [No Abstract]   [Full Text] [Related]  

  • 22. Involvement of an efflux system in high-level fluoroquinolone resistance of Shigella dysenteriae.
    Ghosh AS; Ahamed J; Chauhan KK; Kundu M
    Biochem Biophys Res Commun; 1998 Jan; 242(1):54-6. PubMed ID: 9439608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of resistance to quinolone antimicrobials.
    Smith J
    Chemioterapia; 1987 Jun; 6(2 Suppl):208-9. PubMed ID: 3334558
    [No Abstract]   [Full Text] [Related]  

  • 24. [Observations on the antibacterial effect of polyoxymethyleneurea (polynoxylin) in vitro].
    Wernsdorfer G; Wernsdorfer WH
    Arzneimittelforschung; 1967 Sep; 17(9):1204-7. PubMed ID: 4971132
    [No Abstract]   [Full Text] [Related]  

  • 25. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.
    Akasaka T; Tanaka M; Yamaguchi A; Sato K
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative susceptibility studies of clinically isolated Pseudomonas aeruginosa, Escherichia coli and Klebsiella spp to cefoperazone and cefotaxime.
    Lee YH; Hussain ZA; Choong FP
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(3):299-303. PubMed ID: 2125616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple resistance of bacteria of clinical origin.
    Mitsuhashi S
    Jpn J Med Sci Biol; 1968 Jun; 21(3):217-20. PubMed ID: 4881254
    [No Abstract]   [Full Text] [Related]  

  • 28. Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer--is it justified?
    Murphy M; Brown AE; Sepkowitz KA; Bernard EM; Kiehn TE; Armstrong D
    Clin Infect Dis; 1997 Aug; 25(2):346-8. PubMed ID: 9332551
    [No Abstract]   [Full Text] [Related]  

  • 29. Minimum inhibitory concentrations of some newly developed antimicrobials against common urinary and blood pathogens.
    el-Baz W; Hamid TA; Sabbour MS
    Chemioterapia; 1987 Jun; 6(2 Suppl):40-2. PubMed ID: 3151347
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical perspectives of quinolone resistance in Pseudomonas aeruginosa.
    Dalhoff A
    Antibiot Chemother (1971); 1991; 44():221-39. PubMed ID: 1801641
    [No Abstract]   [Full Text] [Related]  

  • 31. [Phenotypes of resistance to antibiotics of the most frequently isolated strains in five specialized hospital centers. Multicenter study].
    Gabastou JM; Chouaki T; Mangeot J; Zemir A; Manuel C; Lepitre M; Gravisse J; Cornel E; Denis-Jacquot N; Mahuzier G
    Pathol Biol (Paris); 1995 Apr; 43(4):320-3. PubMed ID: 7567123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glycol ethers as solvents in resistance tests].
    Höhne C; Patsch R
    Zentralbl Bakteriol Orig; 1969; 211(1):81-7. PubMed ID: 4990089
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bacteriologic studies with carbenicillin].
    Blasius C; Menz HP; Sander J
    Dtsch Med Wochenschr; 1969 Nov; 94(48):2501-4. PubMed ID: 4981855
    [No Abstract]   [Full Text] [Related]  

  • 34. Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.
    Gutmann L; Williamson R; Moreau N; Kitzis MD; Collatz E; Acar JF; Goldstein FW
    J Infect Dis; 1985 Mar; 151(3):501-7. PubMed ID: 2982966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late quinolone resistance in Pseudomonas aeruginosa.
    Smith JM; Hashmi ZS
    J Antimicrob Chemother; 1991 Apr; 27(4):555-6. PubMed ID: 1906859
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug resistance of Pseudomonas aeruginosa with special reference to new quinolones.
    Iyobe S; Hirai K; Hashimoto H
    Antibiot Chemother (1971); 1991; 44():209-14. PubMed ID: 1801639
    [No Abstract]   [Full Text] [Related]  

  • 37. Quinolone resistance in Pseudomonas aeruginosa.
    Hashmi ZS; Smith JM
    J Antimicrob Chemother; 1994 Apr; 33(4):881-3. PubMed ID: 8056710
    [No Abstract]   [Full Text] [Related]  

  • 38. Resistance to quinolones in gram-negative microorganisms: mechanisms and prevention.
    Baquero F
    Eur Urol; 1990; 17 Suppl 1():3-12. PubMed ID: 2162298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Resistance to antibiotics caused by decrease of the permeability in gram-negative bacteria].
    Nguyen Van JC; Gutmann L
    Presse Med; 1994 Mar; 23(11):522, 527-31. PubMed ID: 8022741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mode of action and development of resistance to quinolones.
    Cullmann W
    Antibiot Chemother (1971); 1989; 42():287-300. PubMed ID: 2512843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.